Ongoing efforts are focused on developing mouse models that spontaneously develop oral SCCs, which will enable mechanistic studies to confirm the protective roles of ADH5 and ALDH3 enzymes in maintaining genome stability and preventing cancer development. The gene discussed is ADH5; the disease is cancer.